Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder

Psychiatry Research - Neuroimaging

Volumn 221, Issue 2, 2014, Pages 155-161

  Ruhé, Henricus G ^a,b   Koster, Michiel ^a   Booij, Jan ^a   van Herk, Marcel ^c   Veltman, Dick J ^d   Schene, Aart H ^a,e,f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Amygdala; Functional magnetic resonance imaging; Major depressive disorder; Paroxetine; Serotonin transporter; Single photon emission computed tomography

Indexed keywords

AMYGDALA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MAJOR DEPRESSIVE DISORDER; PAROXETINE; SEROTONIN TRANSPORTER; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ADULT; AMYGDALA; COCAINE; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FACIAL EXPRESSION; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 84895068039     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2013.12.003     Document Type: Article

References (44)

1. Adolphs R. Neural systems for recognizing emotion. Current Opinion in Neurobiology 2002, 12:169-177.
2. Bigos K.L., Pollock B.G., Aizenstein H.J., Fisher P.M., Bies R.R., Hariri A.R. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33:3221-3225.
3. Blier P., De Montigny C. Current advances and trends in the treatment of depression. Trends in Pharmacological Science 1994, 15:220-226.
4. Burke S.M., van de Giessen E., de Win M., Schilt T., van Herk M., van den B.W., Booij J. Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects. Psychological Medicine 2011, 41:419-429.
5. Chen C.H., Suckling J., Ooi C., Fu C.H., Williams S.C., Walsh N.D., Mitterschiffthaler M.T., Pich E.M., Bullmore E. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 2008, 33:1909-1918.
6. Costafreda S.G., Brammer M.J., David A.S., Fu C.H. Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies. Brain Research Reviews 2008, 58:57-70.
7. De Win M.M., Jager G., Booij J., Reneman L., Schilt T., Lavini C., Olabarriaga S.D., Den Heeten G.J., van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 2008, 131:2936-2945.
8. De Win M.M., Jager G., Vervaeke H.K., Schilt T., Reneman L., Booij J., Verhulst F.C., Den Heeten G.J., Ramsey N.F., Korf D.J., van den B.W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research 2005, 14:167-185.
9. Del Ben C.M., Deakin J.F., McKie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., Anderson I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 2005, 30:1724-1734.
10. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Annals of the New York Academy of Science 1999, 877:614-637.
11. Ekman P., Friesen W. Pictures of Facial Affect 1976, Consulting Psychologists, Palo Alto, CA.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders patient edition (SCID-I/P version 2.0). Groenestijn MAC 1999, Swets & Zeitlinger B.V., Lisse, the Netherlands (Translated in Dutch). G.W. Akkerhuis, R.W. Kupka, N. Schneider, W.A. Nolen (Eds.).
13. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., Andrew C.M., Pich E.M., Williams P.M., Reed L.J., Mitterschiffthaler M.T., Suckling J., Bullmore E.T. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry 2004, 61:877-889.
14. Fuller R.W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sciences 1994, 55:163-167.
15. Ghaemi M., Hilker R., Rudolf J., Sobesky J., Heiss W.D. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. Journal of Neurology Neurosurgery and Psychiatry 2002, 73:517-523.
16. Groenewold N.A., Opmeer E.M., de Jonge P., Aleman A., Costafreda S.G. Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. Neuroscience Biobehavioural Reviews 2013, 37:152-163.
17. Halberstadt A.L., Balaban C.D. Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdala. Journal of Chemical Neuroanatomy 2008, 35:317-325.
18. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960, 23:56-61.
19. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry 2005, 62:146-152.
20. Hariri A.R., Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends in Cognitive Sciences 2006, 10:182-191.
21. Harmer C.J., Goodwin G.M., Cowen P.J. Why do antidepressants take so long to workα A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry 2009, 195:102-108.
22. Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., Goodwin G.M. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biological Psychiatry 2006, 59:816-820.
23. Heidbreder C.A., Groenewegen H.J. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neuroscience Biobehavioural Reviews 2003, 27:555-579.
24. Holmes A., Yang R.J., Lesch K.P., Crawley J.N., Murphy D.L. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 2003, 28:2077-2088.
25. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. Journal of Cerebral Blood Flow and Metabolism 2007, 27:1533-1539.
26. LeDoux J. The amygdala. Current Biology 2007, 17:R868-R874.
27. Matthews S.C., Strigo I.A., Simmons A.N., Yang T.T., Paulus M.P. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. Journal of Affective Disorders 2008, 111:13-20.
28. 11C]DASB positron emission tomography study. American Journal of Psychiatry. 2004, 161:826-835.
29. Murphy S.E., Norbury R., O'Sullivan U., Cowen P.J., Harmer C.J. Effect of a single dose of citalopram on amygdala response to emotional faces. British Journal of Psychiatry 2009, 194:535-540.
30. O'Rourke H., Fudge J.L. Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders. Biological Psychiatry 2006, 60:479-490.
31. 11C]DASB and positron emission tomography. Biological Psychiatry 2006, 59:821-828.
32. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biological Psychiatry 2003, 54:515-528.
33. Phillips M.L., Ladouceur C.D., Drevets W.C. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Molecular Psychiatry 2008, 13(9):829-857.
34. Rhodes R.A., Murthy N.V., Dresner M.A., Selvaraj S., Stavrakakis N., Babar S., Cowen P.J., Grasby P.M. Human 5-HT transporter availability predicts amygdala reactivity in vivo. Journal of Neuroscience 2007, 27:9233-9237.
35. Ruhe H.G., Huyser J., Swinkels J.A., Schene A.H. Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review. British Journal of Psychiatry 2006, 189:309-316.
36. 123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender. European Journal of Nuclear Medicine and Molecular Imaging 2009, 36:841-849.
37. Ruhe H.G., Booij J., Weert H.C.v., Reitsma J.B., Franssen E.J.F., Michel M.C., Schene A.H. Evidence why dose-escalation of paroxetine in major depressive disorder is not effective: a 6-week, randomized-controlled trial with assessment of serotonin transporter occupancy. Neuropsychopharmacology 2009, 34:999-1010.
38. Ruhe H.G., Ooteman W., Booij J., Michel M.C., Moeton M., Baas F., Schene A.H. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder. Pharmacogenetics and Genomics 2009, 19:67-76.
39. Ruhe H.G., Booij J., Veltman D.J., Michel M.C., Schene A.H. Successful pharmacological treatment of major depressive disorder attenuates amygdala activation to negative facial expressions. An fMRI study. Journal of Clinical Psychiatry 2012, 73:451-459.
40. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biological Psychiatry 2001, 50:651-658.
41. Smith H.R., Porrino L.J. The comparative distributions of the monoamine transporters in the rodent, monkey, and human amygdala. Brain Structure and Function 2008, 213:73-91.
42. Victor T.A., Furey M.L., Fromm S.J., Ohman A., Drevets W.C. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Archives of General Psychiatry 2010, 67:1128-1138.
43. Wolfensberger S.P.A., Veltman D.J., Hoogendijk W.J.G., Boomsma D.I., de Geus E.J.C. Amygdala responses to emotional faces in twins discordant or concordant for the risk for anxiety and depression. NeuroImage 2008, 41:544-552.
44. Wolthaus J.W., van Herk M., Muller S.H., Belderbos J.S., Lebesque J.V., de Bois J.A., Rossi M.M., Damen E.M. Fusion of respiration-correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans. Physics in Medicine and Biology 2005, 50:1569-1583.